These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 18588561)

  • 1. Stability of asthma control with regular treatment: an analysis of the Gaining Optimal Asthma controL (GOAL) study.
    Bateman ED; Bousquet J; Busse WW; Clark TJ; Gul N; Gibbs M; Pedersen S;
    Allergy; 2008 Jul; 63(7):932-8. PubMed ID: 18588561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asthma control over 3 years in a real-life study.
    Lundbäck B; Rönmark E; Lindberg A; Jonsson AC; Larsson LG; James M
    Respir Med; 2009 Mar; 103(3):348-55. PubMed ID: 19042115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
    Maspero J; Guerra F; Cuevas F; Gutierrez JP; Soto-Ramos M; Anderton S; Mechali D; Chan R; Pedersen S
    Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of response to fluticasone propionate and salmeterol/fluticasone propionate combination in the Gaining Optimal Asthma controL study.
    Pedersen SE; Bateman ED; Bousquet J; Busse WW; Yoxall S; Clark TJ;
    J Allergy Clin Immunol; 2007 Nov; 120(5):1036-42. PubMed ID: 17935765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective study of the use of fluticasone propionate/salmeterol combination as initial asthma controller therapy in a commercially insured population.
    Friedman H; Wilcox T; Reardon G; Crespi S; Yawn BP
    Clin Ther; 2008 Oct; 30(10):1908-17. PubMed ID: 19014847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does measuring BHR add to guideline derived clinical measures in determining treatment for patients with persistent asthma?
    Koenig SM; Murray JJ; Wolfe J; Andersen L; Yancey S; Prillaman B; Stauffer J; Dorinsky P
    Respir Med; 2008 May; 102(5):665-73. PubMed ID: 18328683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compliance with maintenance treatment of asthma (ADERE study).
    Chatkin JM; Cavalet-Blanco D; Scaglia NC; Tonietto RG; Wagner MB; Fritscher CC
    J Bras Pneumol; 2006; 32(4):277-83. PubMed ID: 17268725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Is guideline-defined asthma control achievable?--secondary publication. The Gaining Optimal Asthma ControL (GOAL) Study].
    Pedersen SE
    Ugeskr Laeger; 2005 Sep; 167(38):3595-7. PubMed ID: 16219190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists.
    Murray J; Rosenthal R; Somerville L; Blake K; House K; Baitinger L; VanderMeer A; Dorinsky P
    Ann Allergy Asthma Immunol; 2004 Oct; 93(4):351-9. PubMed ID: 15521371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma Control study.
    Barnes NC
    Am J Respir Crit Care Med; 2004 Oct; 170(8):830-1. PubMed ID: 15475405
    [No Abstract]   [Full Text] [Related]  

  • 11. Salmeterol/fluticasone propionate combination product in asthma. An evaluation of its cost effectiveness vs fluticasone propionate.
    Pharmacoeconomics; 1999; 16 Suppl 2():i-viii, 1-34. PubMed ID: 10724799
    [No Abstract]   [Full Text] [Related]  

  • 12. EXCEL: A randomised trial comparing salmeterol/fluticasone propionate and formoterol/budesonide combinations in adults with persistent asthma.
    Dahl R; Chuchalin A; Gor D; Yoxall S; Sharma R
    Respir Med; 2006 Jul; 100(7):1152-62. PubMed ID: 16675212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
    Pearlman DS; Stricker W; Weinstein S; Gross G; Chervinsky P; Woodring A; Prillaman B; Shah T
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
    Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
    Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initiation of maintenance treatment with salmeterol/fluticasone propionate 50/100 microg bd versus fluticasone propionate 100 microg bd alone in patients with persistent asthma: integrated analysis of four randomised trials.
    Barnes NC; Jacques L; Goldfrad C; Bateman ED
    Respir Med; 2007 Nov; 101(11):2358-65. PubMed ID: 17689947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initiation of maintenance therapy with salmeterol/fluticasone propionate combination therapy in moderate asthma: a comparison with fluticasone propionate.
    Rojas RA; Paluga I; Goldfrad CH; Duggan MT; Barnes N
    J Asthma; 2007; 44(6):437-41. PubMed ID: 17654129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective claims study of fluticasone propionate/salmeterol fixed-dose combination use as initial asthma controller therapy in children despite guideline recommendations.
    Friedman HS; Eid NS; Crespi S; Wilcox TK; Reardon G
    Clin Ther; 2009 May; 31(5):1056-63. PubMed ID: 19539106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A rational combination for the treatment of asthma. Salmeterol and fluticasone in one preparation].
    Wettengel R; Steinkamp G
    Pneumologie; 1999 Sep; 53(9):426-32. PubMed ID: 10544652
    [No Abstract]   [Full Text] [Related]  

  • 19. New study shows asthmatics can live free of symptoms.
    West Afr J Med; 2005; 24(4):342. PubMed ID: 16483054
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of fluticasone propionate-salmeterol therapy on seasonal changes in airway responsiveness and exhaled nitric oxide levels in patients with pollen-induced asthma.
    Prieto L; Gutiérrez V; Pérez-Francés C; Badiola C; Lanuza A; Bruno L; Ferrer A
    Ann Allergy Asthma Immunol; 2005 Nov; 95(5):452-61. PubMed ID: 16312168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.